Latest filing published 14 Jul 2017 for Coupa Software Inc, €45.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
MDV IX LP: trading record in brief
MDV IX LP is a declared insider at 2 companies; the most frequent names are Adamas Pharmaceuticals Inc and Coupa Software Inc. Between 17 March 2015 and 12 July 2017, the trades on record add up to 21 filings.
Market trades split into 8 purchases (€3.6M) and 12 sales (€72.1M). Taken together, the sales exceed the purchases by €68.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2017 to date brings no purchases and 2 sales.
Half of the purchases are above €443k and half below. Of 8 purchases, 8 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 14 July 2017: an open-market sale of €45.5M, in Coupa Software Inc. The most recent open-market purchase was published on 16 September 2016, 3,706 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to MDV IX LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,662,000 shares@ US$31.2567.0% of flowCommon StockSEC:0001209191-17-045231:0
- 1,000,000 shares@ US$24.0533.0% of flowCommon StockSEC:0001209191-17-027727:0
- 6,648,700 sharesCommon StockSEC:0001209191-16-145895:0
- 54,537 shares@ US$16.425322.0% of flowCommon StockSEC:0001209191-16-141889:0Canonical exit: 13 Dec 2016 (T+90)
- 200 shares@ US$16.500.1% of flowCommon StockSEC:0001209191-16-141889:1Canonical exit: 14 Dec 2016 (T+90)
- 8,240 shares@ US$16.80793.4% of flowCommon StockSEC:0001209191-16-141889:2Canonical exit: 15 Dec 2016 (T+90)
- 22,342 shares@ US$15.65378.6% of flowCommon StockSEC:0001209191-16-141471:0Canonical exit: 11 Dec 2016 (T+90)
- 62,034 shares@ US$15.555923.8% of flowCommon StockSEC:0001209191-16-141471:1Canonical exit: 12 Dec 2016 (T+90)
- 60,846 shares@ US$15.6823.5% of flowCommon StockSEC:0001209191-16-140846:0Canonical exit: 6 Dec 2016 (T+90)
- 43,719 shares@ US$14.751515.9% of flowCommon StockSEC:0001209191-16-140473:0Canonical exit: 1 Dec 2016 (T+90)
- 7,200 shares@ US$14.99722.7% of flowCommon StockSEC:0001209191-16-140473:1Canonical exit: 5 Dec 2016 (T+90)
- 8,657 shares@ US$27.5278Common StockSEC:0001209191-15-060844:0
- 25,737 shares@ US$27.5452Common StockSEC:0001209191-15-060272:0
- 3,100 shares@ US$27.551Common StockSEC:0001209191-15-060272:1
- 15,842 shares@ US$27.5376Common StockSEC:0001209191-15-055487:0
- 7,483 shares@ US$18.017Common StockSEC:0001209191-15-048533:0
- 112,073 shares@ US$18.02Common StockSEC:0001209191-15-048533:1
- 1,643 shares@ US$18.04Common StockSEC:0001209191-15-045100:0
- 37,078 shares@ US$18.557Common StockSEC:0001209191-15-034141:0
- 4,523 shares@ US$18.00Common StockSEC:0001209191-15-028056:0
- 7,200 shares@ US$18.0407Common StockSEC:0001209191-15-028056:1
21 of 21 declarations